Asymmetry Capital Management as of June 30, 2021
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 30 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Centene Corporation (CNC) | 8.2 | $12M | 165k | 72.93 | |
Astrazeneca Plc-spons Adr (AZN) | 7.2 | $11M | 176k | 59.90 | |
Sotera Health (SHC) | 7.0 | $10M | 421k | 24.23 | |
Arena Pharmaceuticals | 6.7 | $9.7M | 142k | 68.20 | |
Mirati Therapeutics | 6.4 | $9.4M | 58k | 161.52 | |
Jazz Pharmaceuticals (JAZZ) | 6.4 | $9.4M | 53k | 177.64 | |
Insulet Corporation (PODD) | 5.5 | $7.9M | 29k | 274.51 | |
Alkermes (ALKS) | 5.1 | $7.5M | 305k | 24.52 | |
Adaptive Biotechnologies Cor (ADPT) | 4.7 | $6.9M | 168k | 40.86 | |
Essa Pharma (EPIX) | 4.2 | $6.1M | 213k | 28.57 | |
Kymera Therapeutics (KYMR) | 4.1 | $6.0M | 123k | 48.50 | |
Aclaris Therapeutics (ACRS) | 3.8 | $5.5M | 316k | 17.56 | |
Mereo Biopharma Group Pl- Adr (MREO) | 3.5 | $5.1M | 1.6M | 3.17 | |
Biodesix (BDSX) | 3.5 | $5.0M | 381k | 13.21 | |
Aslan Pharmaceuticals Lt- Adr | 2.7 | $3.9M | 1.2M | 3.30 | |
Pmv Pharmaceuticals (PMVP) | 2.4 | $3.5M | 102k | 34.16 | |
Hologic (HOLX) | 2.1 | $3.1M | 46k | 66.71 | |
Guardant Health (GH) | 2.1 | $3.0M | 24k | 124.21 | |
Amicus Therapeutics (FOLD) | 2.0 | $2.9M | 299k | 9.64 | |
Avadel Pharmaceuticals Adr | 1.8 | $2.7M | 400k | 6.73 | |
Argenx Se - Adr (ARGX) | 1.7 | $2.4M | 8.1k | 301.09 | |
Forte Biosciences | 1.5 | $2.2M | 66k | 33.62 | |
Bio-Rad Laboratories (BIO) | 1.3 | $1.9M | 3.0k | 644.18 | |
Iteos Therapeutics (ITOS) | 1.1 | $1.6M | 61k | 25.65 | |
Graphite Bio | 1.1 | $1.6M | 51k | 30.72 | |
Seres Therapeutics (MCRB) | 1.0 | $1.5M | 63k | 23.85 | |
Verve Therapeutics (VERV) | 1.0 | $1.5M | 25k | 60.27 | |
Regulus Therapeutics | 0.8 | $1.2M | 1.5M | 0.81 | |
Bcls Acquisition Corp | 0.6 | $877k | 83k | 10.53 | |
Galecto | 0.2 | $308k | 61k | 5.05 |